Our most recent episode of The Expert Series podcast explores the newly released SLE treatment guidelines and how they might affect patient care.

Patients newly diagnosed with PAH are often undertreated relative to treatment recommendations outlined in current guidelines.

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

Treatments for are allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia under review.